Clinical trial
Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs…
NCT00492635 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00492635 |
|---|---|
| Title | Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED |
| Official title | A Randomized, Double-blind, Double-dummy, Multicenter Parallel Group Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil Versus Vardenafil PRN Versus Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving Erectile Function |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Erectile Dysfunction, Sexual Dysfunction, Physiological |
| Intervention type | Drug |
| Interventions | Levitra (Vardenafil, BAY38-9456), Placebo |
| Enrollment | 628 |
| Start date | Dec 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jun 27, 2007 |
| Last update posted | Oct 28, 2014 |
| Countries | Austria, Belgium, Canada, Finland, France, Germany, Italy, Netherlands, Norway, South Africa, Spain, Sweden and 3 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: